Biosimilars

GPTKB entity

Statements (63)
Predicate Object
gptkbp:instance_of gptkb:chemical_compound
gptkbp:approves gptkb:FDA
gptkbp:are a topic of ongoing research
a focus of international collaborations
used in autoimmune diseases
considered a sustainable option
subject to market competition
part of global health initiatives
a focus of Biocon's R& D efforts
a growing segment of the pharmaceutical market
a key area for investment by Biocon
a part of Biocon's portfolio
a response to the high cost of biologics
a solution for unmet medical needs
an alternative to traditional drugs
developed through biological processes
expected to expand in the next decade
gaining popularity in emerging markets
increasingly used in oncology
influenced by healthcare policies
involved in global supply chains
not identical to reference products
part of personalized medicine
produced in living systems
subject to patent litigation
subject to post-marketing surveillance
therapeutically equivalent to reference products
used in diabetes management
used in hematology
gptkbp:benefits patent expirations
gptkbp:can_be interchanged with reference products
gptkbp:can_involve cell culture techniques
protein purification processes
gptkbp:clinical_trial gptkb:Biocon
gptkbp:cost_less_than original biologics
gptkbp:developed_by gptkb:Biocon
https://www.w3.org/2000/01/rdf-schema#label Biosimilars
gptkbp:impact healthcare costs
gptkbp:include gptkb:diabetes
growth factors
monoclonal antibodies
fusion proteins
biosimilar adalimumab
biosimilar filgrastim
biosimilar pegfilgrastim
biosimilar rituximab
biosimilar trastuzumab
gptkbp:is_regulated_by gptkb:EMA
gptkbp:is_similar_to reference biologics
gptkbp:is_subject_to regulatory guidelines
interchangeability studies
gptkbp:manufacturer gptkb:Biocon
gptkbp:marketed_as various brand names
gptkbp:promotes patient access to therapies
gptkbp:requires quality assurance measures
comparative clinical studies
gptkbp:targets chronic diseases
gptkbp:used_for treatment of diseases
gptkbp:bfsParent gptkb:Samsung_Bioepis
gptkb:AMGN
gptkb:Teva_Europe
gptkb:Sun_Pharmaceutical_Industries
gptkbp:bfsLayer 5